Synergistic Effects of Multiple Factors Involved in COVID-19-dependent Muscle Loss.
Ontology highlight
ABSTRACT: The COVID-19 pandemic caused by the novel SARS-CoV-2 coronavirus is an ongoing pandemic causing severe health crisis worldwide. Recovered COVID-19 patients go through several long-term side effects such as fatigue, headaches, dizziness, weight loss, and muscle loss among others. Our study sought to determine the molecular mechanisms behind muscle loss in COVID-19 patients. We hypothesized that multiple factors such as cytokine storm and therapeutic drugs (glucocorticoid and antiviral drugs) might be involved in muscle loss. Using the Gene Expression Omnibus database, we identified several studies that performed RNA sequencing on skeletal muscles with the treatment of cytokine, glucocorticoid, and antiviral drugs. Our study identified cytokines, such as IL-1b, and IL-6, associated with alte
SUBMITTER: Cantu N
PROVIDER: S-EPMC8947833 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA